---
title: "GLOBAL BIO-CHEM has completed the issuance of consideration shares and the conversion of convertible bonds based on special authorization"
type: "News"
locale: "zh-HK"
url: "https://longbridge.com/zh-HK/news/259774527.md"
description: "GLOBAL BIO-CHEM announced that it has completed the relevant procedures for the issuance of consideration shares and the conversion of convertible bonds under special authorization. According to the share purchase agreement, a total of 2.753 billion consideration shares have been issued. At the same time, bondholders have exercised their conversion rights, converting HKD 1.086 billion of convertible bonds into 5.173 billion conversion shares, with a conversion price of HKD 0.21 per share. All newly issued shares have equal status with existing shares"
datetime: "2025-10-02T11:26:03.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/259774527.md)
  - [en](https://longbridge.com/en/news/259774527.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/259774527.md)
---

> 支持的語言: [简体中文](https://longbridge.com/zh-CN/news/259774527.md) | [English](https://longbridge.com/en/news/259774527.md)


# GLOBAL BIO-CHEM has completed the issuance of consideration shares and the conversion of convertible bonds based on special authorization

According to the announcement from Da Cheng Bio-Chem Technology (00809), the board of directors is pleased to announce that all conditions precedent under Share Purchase Agreement I and Share Purchase Agreement II have been fulfilled, and in accordance with the terms and conditions of each Share Purchase Agreement, the share purchase agreements were completed on October 2, 2025. A total of 2.753 billion consideration shares have been issued.

The company has received a conversion notice from bondholders regarding the full exercise of their conversion rights under the convertible bond, converting a principal amount of HKD 1.086 billion of convertible bonds into 5.173 billion conversion shares at a conversion price of HKD 0.21 per conversion share. Therefore, after completing the necessary administrative procedures for the issuance of conversion shares, the company has issued and allotted 5.173 billion conversion shares to the bondholders on October 2, 2025, which rank equally with each other and all other existing issued shares in all respects (conversion)

### 相關股票

- [GLOBAL BIO-CHEM (00809.HK)](https://longbridge.com/zh-HK/quote/00809.HK.md)

## 相關資訊與研究

- [ZAWYA: NBK resumes Al Jawhara prize draws](https://longbridge.com/zh-HK/news/281466379.md)
- [Nu-Med Plus Delays Annual 10-K Filing](https://longbridge.com/zh-HK/news/281262758.md)
- [Bakkafrost Posts Solid Q1 Harvests but Faces Freshwater Costs in Scotland](https://longbridge.com/zh-HK/news/281451120.md)
- [Genova Property Group Publishes Swedish Annual Report for 2025](https://longbridge.com/zh-HK/news/281215055.md)
- [Transactions with Shares and Linked Securities in Genmab A/S Made by Managerial Employees and Their Closely Associated Persons](https://longbridge.com/zh-HK/news/281415009.md)